文献速递免疫规划

重组二价COVID-19疫苗在小鼠和恒河猴中的免疫原性与保护效果

Immunogenicity and protective effects of recombinant bivalent COVID-19 vaccine in mice and rhesus macaques.
PubMed 文献 · Vaccine · 2023-06-30

研究报道一种含原型株和beta变异株RBD蛋白的重组二价COVID-19疫苗,在小鼠中免疫原性远高于已上市单价重组蛋白疫苗ZF2001,对原始株和多种变异株均有良好免疫效果;恒河猴攻毒实验显示该疫苗大幅降低肺部病毒载量并减少肺部病变。

要点

  • 该二价疫苗含原型株和beta变异株的RBD蛋白。
  • 小鼠中免疫原性远高于单价重组蛋白疫苗ZF2001。
  • 恒河猴攻毒后大幅降低肺部病毒载量并减少肺部病变。

核心结论

  • 该二价疫苗对原型株和多种变异株的免疫原性与保护效果远优于单价重组蛋白疫苗,为开发广谱COVID-19疫苗提供重要基础。

研究设计与样本

  • 研究为重组二价COVID-19疫苗(含原型株和beta变异株RBD蛋白)的小鼠免疫原性研究和恒河猴攻毒实验。

主要发现

  • 小鼠中该二价疫苗免疫原性远高于已上市单价重组蛋白COVID-19疫苗ZF2001,对原始COVID-19株和多种变异株均有良好免疫效果。
  • 恒河猴攻毒实验中,该二价疫苗大幅降低SARS-CoV-2感染恒河猴的肺部病毒载量并减少肺部病变。

关键数值与推荐

  • 小鼠中该二价疫苗免疫原性远高于单价重组蛋白疫苗ZF2001。
  • 恒河猴攻毒后肺部病毒载量大幅降低、肺部病变减少。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Coronavirus disease (COVID-19) is still spreading rapidly worldwide, and a safe, effective, and cheap vaccine is still required to combat the COVID-19 pandemic. Here, we report a recombinant bivalent COVID-19 vaccine containing the RBD proteins of the prototype strain and beta variant. Immunization studies in mice demonstrated that this bivalent vaccine had far greater immunogenicity than the ZF2001, a marketed monovalent recombinant protein COVID-19 vaccine, and exhibited good immunization effects against the original COVID-19 strain and various variants. Rhesus macaque challenge experiments showed that this bivalent vaccine drastically decreased the lung viral load and reduced lung lesions in SARS-CoV-2 (the causative virus of COVID-19)-infected rhesus macaques. In summary, this bivalent vaccine showed immunogenicity and protective efficacy that was far superior to the monovalent recombinant protein vaccine against the prototype strain and provided an important basis for developing broad-spectrum COVID-19 vaccines.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Liu Y, Zhang A, Wang Y, et al. Immunogenicity and protective effects of recombinant bivalent COVID-19 vaccine in mice and rhesus macaques. Vaccine. 2023. PMID: 37451875. doi:10.1016/j.vaccine.2023.06.086

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。